Seeking Alpha

Endo Pharmaceuticals (ENDP): Q2 EPS of $1.05 misses by $0.01. Revenue of $608M (+53.2% Y/Y)...

Endo Pharmaceuticals (ENDP): Q2 EPS of $1.05 misses by $0.01. Revenue of $608M (+53.2% Y/Y) misses by $11.25M. Sees FY11 EPS of $4.55-4.65; revenue of $2.72-2.80B. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|